When.com Web Search

  1. Ads

    related to: dulera inhaler cost without insurance

Search results

  1. Results From The WOW.Com Content Network
  2. Some drugmakers to cap cost of asthma inhalers at $35 a month

    www.aol.com/news/drugmakers-cap-cost-asthma...

    A spokesperson for Boehringer Ingelheim said the $35 cap will be automatically applied at the pharmacy counter for the majority of eligible patients with commercial insurance. For those without ...

  3. Boehringer to cut out-of-pocket costs for inhalers to $35 - AOL

    www.aol.com/news/boehringer-cut-pocket-costs...

    (Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...

  4. AstraZeneca capping COPD, asthma medications at $35 a month - AOL

    www.aol.com/news/astrazeneca-capping-copd-asthma...

    For premium support please call: 800-290-4726 more ways to reach us

  5. Mometasone/formoterol - Wikipedia

    en.wikipedia.org/wiki/Mometasone/formoterol

    Mometasone/formoterol, sold under the brand name Dulera among others, is a fixed-dose combination medication used in the long-term treatment of asthma. [1] It contains mometasone a steroid and formoterol a long-acting beta agonist. [1] It is only recommended in those for whom an inhaled steroid is not sufficient. [1] It is used by inhalation. [1]

  6. Fact check: Yes, the price of an inhaler in the U.S. is ... - AOL

    www.aol.com/fact-check-yes-price-inhaler...

    “Big drug companies charge as little as $7 for an inhaler overseas and nearly $500 for the exact same one here in the US,” Baldwin said Feb. 1, 2024 in a Facebook post.. “That has got to end.

  7. Prescription drug prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Prescription_drug_prices...

    Prescription drug list prices in the United States continually are among the highest in the world. [1] [2] The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015.